In Germany, the incidence of coronavirus has reached a new peak | News from Germany about Russia | DW

Germany has recorded a new peak in the spread of coronavirus. The infection rate of SARS-CoV-2 in Germany, as of Tuesday morning, January 18, increased to 553.2 per hundred thousand population, the Robert Koch Institute (RKI) reported. Just the day before, this figure was 528.2, and a week earlier – 387.9.

Over the past day, 74,405 new cases of coronavirus infection were registered in the country (45,690 a week earlier). For the entire duration of the pandemic in Germany, according to official figures, SARS-CoV-2 has already infected 8,074,527 people. The actual number of infections, however, should be much higher, as many cases remain unrecognized.

COVID-19 deaths are on the decline

At the same time, the death rate from covid in Germany is declining. Over the past day, 193 deaths have been registered in the country. A week earlier, there were 322. During the entire period of the pandemic, 115,842 people have already become victims of covid in Germany.

The workload of intensive care units in German clinics has also decreased – one of the most important indicators on the basis of which anti-coronavirus restrictions are tightened or weakened in Germany.

According to the latest data, this ratio has dropped to 3.14 per hundred thousand of the population. Only a day earlier it was 3.24.

See also:

• What vaccines humanity is vaccinated against coronavirus

  BioNTech/Pfizer: the beginning of the mRNA revolution

  The first COVID-19 vaccine approved for use in the US and the EU was the development of German scientists with Turkish roots Ugur Sahin and his wife Ozlem Turechi. Their Mainz-based BioNTech formed an alliance with the American giant Pfizer, and the vaccine became known as “Pfizer’s.” In 2021, 2 billion doses will be produced. The media has been talking about a “revolution” in pharmaceuticals, as the first mRNA vaccine has been created.

• 

  What vaccines humanity is vaccinated against coronavirus

  Moderna: hailing from Harvard University

  The American biotechnology company Moderna also specializes in RNA technologies, which are considered a new word in medicine. Its headquarters is located in Cambridge, Massachusetts, near Harvard University, whose scientists founded the firm in 2010. The Moderna vaccine, created with financial support from the authorities, became the second one registered in the US and the EU at the turn of 2020-21.

• 

  What vaccines humanity is vaccinated against coronavirus

  AstraZeneca has the “Oxford vaccine”

  Scientists at Oxford University have entered into an alliance with the British-Swedish company AstraZeneca for clinical trials and production of their vaccine. It largely ensures the vaccination of the inhabitants of the UK, fulfills a large order from the EU and actively works with developing countries, because the “Oxford vaccine” has a very low price. So, in India it is produced for the local market and for export.

• 

  What vaccines humanity is vaccinated against coronavirus

  “Sputnik V”: the very first registration

  In August 2020, Russia announced that it had registered the world’s first coronavirus vaccine, called Sputnik V. Mass vaccination of the Russian population officially began in January 2021. This vector vaccine, developed by scientists at the Gamaleya Center in Moscow, is being promoted to foreign markets by the Russian Direct Investment Fund (RDIF). Pictured: the arrival of the first batch in Bolivia.

• 

  What vaccines humanity is vaccinated against coronavirus

  Sinovac: a silent competitor from China

  Without fanfare or detailed reports of clinical trial results, China has developed at least three vaccines. One of them, created on the basis of an inactivated (killed) coronavirus, was tested by Sinovac Biotech in several Asian countries, including Indonesia, which then purchased it. To set an example for his compatriots, President Joko Widodo was the first to inoculate.

• 

  What vaccines humanity is vaccinated against coronavirus

  CureVac: Tesla Vaccine Printer

  Registration of the second German mRNA vaccine is still being postponed: it is not effective enough, the CureVac company, which entered into an alliance with Bayer, reported in June 2021. This frustrates the plan to manufacture it directly in clinics around the world. A sample of a mobile printer created by its German subsidiary Tesla Grohmann, Elon Musk (in the center) demonstrated in the summer of 2020 to the deputies of the Bundestag.

• 

  What vaccines humanity is vaccinated against coronavirus

  Sanofi: two failures and help for the EU

  The French pharmaceutical company Sanofi is one of the world’s largest manufacturers of vaccines. But this time, it failed twice: neither the joint development with the British GlaxoSmithKline, nor the attempt to create an mRNA vaccine has yet given the desired result. To help supply EU countries, its Frankfurt am Main plant (pictured) will produce 125 million doses of the BioNTech/Pfizer vaccine over the summer.

• 

  What vaccines humanity is vaccinated against coronavirus

  Johnson&Johnson: one dose is enough

  One of the six manufacturers of coronavirus vaccines with which the EU has entered into preliminary supply agreements is the American corporation Johnson & Johnson. Her vector vaccine only requires one shot, not two, and is stored in conventional refrigerators. For the EU, the vaccine, registered on March 11, 2021, will be produced by the Belgian subsidiary of the corporation, Janssen.

  Author: Andrey Gurkov

.